Michael Landsittel, CHIEF FINANCIAL OFFICER at Blueprint Medicines Corp (BPMC), sold 10,006 shares at $90.69 ($907K) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Seasonal sale ($907k) by CHIEF FINANCIAL OFFICER — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.69 | 5,003 | $454K | 50.0% |
| 2 | $90.69 | 5,003 | $454K | 50.0% |
| Total | $90.69 avg | 10,006 | $907K | 100% |
| Filing → |
| BPMC | SELL | 2024-05-17 | $824K | — | Filing → |
| BPMC | SELL | 2024-05-06 | $1.1M | — | Filing → |
| BPMC | SELL | 2024-04-01 | $475K | — | Filing → |